Kisqali (ribociclib) - Novartis
Kisqali: OS data from P3 MONALEESA-2 trial (NCT01958021) for postmenopausal women with advanced breast cancer in H2 2020 (Novartis) - Jan 29, 2020 - Q4 and FY 2019 Results 
P3 data
https://www.novartis.com/sites/www.novartis.com/files/q4-2019-investor-presentation.pdf
 
Jan 29, 2020
 
 
f821b675-bc5b-4f3b-823e-8de18114a63f.jpg